BR9911103A - Antiestrógenos, processo para sua preparação e seu uso farmacêutico - Google Patents

Antiestrógenos, processo para sua preparação e seu uso farmacêutico

Info

Publication number
BR9911103A
BR9911103A BR9911103-9A BR9911103A BR9911103A BR 9911103 A BR9911103 A BR 9911103A BR 9911103 A BR9911103 A BR 9911103A BR 9911103 A BR9911103 A BR 9911103A
Authority
BR
Brazil
Prior art keywords
antiestrogens
preparation
pharmaceutical use
case
antiestrogen
Prior art date
Application number
BR9911103-9A
Other languages
English (en)
Inventor
Ulrich Klar
Rolf Bohlmann
Karsten Parczyk
Karl-Heinrih Fritzemeier
Monika Lessl
Rosemarie Lichtner
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR9911103A publication Critical patent/BR9911103A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/16Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/24All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Patente de Invenção: <B>"ANTIESTRóGENOS, PROCESSO PARA SUA PREPARAçãO E SEU USO FARMACêUTICO"<D>. A presente invenção refere-se a novos antiestrógenos da fórmula geral (I), na qual os substituintes tem os significados mencionados na descrição. Nos novos compostos trata-se a) de um antiestrógeno puro ou b) de um antiestrógeno com efeito estrogênico parcial (estrogênio seletivo de tecidos). Com base nestas propriedades, os novos compostos são apropriados para a preparação de medicamentos;no caso a) por exemplo o tratamento do carcinoma da mama, no caso b) por exemplo para a terapia de reposição hormonal.
BR9911103-9A 1998-06-09 1999-06-09 Antiestrógenos, processo para sua preparação e seu uso farmacêutico BR9911103A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19826213A DE19826213A1 (de) 1998-06-09 1998-06-09 Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
PCT/EP1999/004049 WO1999064393A1 (de) 1998-06-09 1999-06-09 Neue antiestrogene, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Publications (1)

Publication Number Publication Date
BR9911103A true BR9911103A (pt) 2001-03-06

Family

ID=7870694

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911103-9A BR9911103A (pt) 1998-06-09 1999-06-09 Antiestrógenos, processo para sua preparação e seu uso farmacêutico

Country Status (21)

Country Link
US (3) US6166075A (pt)
EP (1) EP1086077B1 (pt)
JP (1) JP2002517482A (pt)
KR (1) KR20010052688A (pt)
CN (1) CN1305457A (pt)
AR (1) AR023629A1 (pt)
AT (1) ATE263755T1 (pt)
AU (1) AU759942B2 (pt)
BR (1) BR9911103A (pt)
CA (1) CA2334780A1 (pt)
CO (1) CO5050355A1 (pt)
DE (2) DE19826213A1 (pt)
DK (1) DK1086077T3 (pt)
ES (1) ES2220072T3 (pt)
HU (1) HUP0102211A3 (pt)
IL (1) IL139863A0 (pt)
PE (1) PE20000541A1 (pt)
PL (1) PL344309A1 (pt)
PT (1) PT1086077E (pt)
WO (1) WO1999064393A1 (pt)
ZA (1) ZA200100201B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826213A1 (de) * 1998-06-09 1999-12-16 Schering Ag Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
US6525069B1 (en) 1998-12-18 2003-02-25 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
DE10039199A1 (de) * 2000-08-10 2002-02-21 Schering Ag Kombinationspräparate aus einem ERß selektiven Estrogen und einem SERM oder Antiestrogen
DE60230017D1 (de) * 2001-02-15 2009-01-08 Janssen Pharmaceutica Nv Farnesyl-protein-transferase hemmer in kombination mit antiöstrogenen
DE10142881A1 (de) * 2001-09-03 2003-04-03 Jomed Gmbh Implantate mit Combretastatin A-4 (CA4)
JP2007503470A (ja) * 2003-05-31 2007-02-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的エストロゲン受容体調節物質としてのシクロヘキシル誘導体
US7750631B2 (en) * 2007-06-22 2010-07-06 Morpho Detection, Inc. Passenger inspection system and methods for using the same
CA2653189A1 (en) 2008-02-04 2009-08-04 University Of Ottawa Estrogenic compounds, process for their production and pharmaceutical uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
FR2744445B1 (fr) * 1996-02-01 1998-10-02 Roussel Uclaf Composes biphenyles nouveaux et/ou a titre de medicament, compositions pharmaceutiques les contenant, leur procede de preparation et les intermediaires de ce procede
DE19826213A1 (de) * 1998-06-09 1999-12-16 Schering Ag Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung

Also Published As

Publication number Publication date
AU759942B2 (en) 2003-05-01
KR20010052688A (ko) 2001-06-25
CO5050355A1 (es) 2001-06-27
CA2334780A1 (en) 1999-12-16
HUP0102211A3 (en) 2002-12-28
US20030162830A1 (en) 2003-08-28
US6166075A (en) 2000-12-26
EP1086077A1 (de) 2001-03-28
AR023629A1 (es) 2002-09-04
US6559181B1 (en) 2003-05-06
PL344309A1 (en) 2001-10-22
ES2220072T3 (es) 2004-12-01
JP2002517482A (ja) 2002-06-18
DE19826213A1 (de) 1999-12-16
PE20000541A1 (es) 2000-08-10
ZA200100201B (en) 2002-01-08
WO1999064393A1 (de) 1999-12-16
IL139863A0 (en) 2002-02-10
DK1086077T3 (da) 2004-08-02
CN1305457A (zh) 2001-07-25
PT1086077E (pt) 2004-08-31
EP1086077B1 (de) 2004-04-07
US7074829B2 (en) 2006-07-11
DE59909123D1 (de) 2004-05-13
ATE263755T1 (de) 2004-04-15
AU4771699A (en) 1999-12-30
HUP0102211A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
EA200100154A1 (ru) Бензоциклогептены, способ их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств
BR0214469A (pt) 17alfa-alquil-17beta-óxi-estratrienos e produtos intermediários para sua preparação, aplicação dos 17alfa-alquil-17beta-óxi-estratrienos para a preparação de medicamentos bem como preparações farmacêuticas
BR9814435A (pt) Novos esteróides antiestrogênicos e composições farmacêuticas associadas
BR9811249A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BRPI0215312B8 (pt) composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto
BR9813373A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
BRPI9909282A (pt) compostos de éter aminociclohexílicos e usos dos mesmos.
BR0111667A (pt) Novos compostos
BR0113176A (pt) Compostos biciclo-pirazol, composições farmacêuticas compreendendo os compostos, uso dos compostos na fabricação de medicamentos, processos para a preparação dos compostos, coleção quìmica combinatória e métodos para o tratamento de mamìferos incluindo humanos utilizando os compostos
BR0106851A (pt) Mistura de conjugados, composição farmacêutica, método de tratar deficiência de insulina em um indivìduo com necéssidade de tal tratamento e processo para sintetizar uma mistura de conjugados
PT1292594E (pt) Derivados de quinazolina para o tratamento de tumores
BR9911072A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépicos e/ou agentes promotores da cura de feridas no trato respiratório inferior
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
HUP9902121A2 (hu) Gonadotropin-leadó hormon antagonista hatású indolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
BR9908094A (pt) Preparado combinado de estrogênio e antiestrogênio
BR0108600A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, métodos para tratamento de uma doença mediada por quimiocina e para tratamento de uma doença inflamatória
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
BR0214634A (pt) Sistemas terapêuticos transdérmicos contendo hormÈnio esteróide e contendo monocaprilato de propilenoglicol
BR9911103A (pt) Antiestrógenos, processo para sua preparação e seu uso farmacêutico
BR0113590A (pt) 7-oxo-piridopirimidinas
HUP0301460A2 (hu) Antiprogresztinek használata hormonfüggő betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállításához
BR9908458A (pt) Tiolésteres de ácido 11beta-benzaldoxim-estra-4,9-dien-carbÈnico substituìdos por s, processos para a sua preparação e preparados farmacêuticos contendo estes compostos
BR9809234A (pt) Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo.
BR0008076A (pt) 16-hidroxiestratrienos como estrogênios de efeito seletivo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6,7 E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.